Plus LibraryBy pinki@katapult.biz / February 13, 2025 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Clear Displaying 1,176 - 1,200 of 2,875 « 1 … 46 47 48 49 50 … 115 » Immunotherapy & targeted Therapy in Melanoma Sanjiv Agarwala, MD View Video Melanoma: Novel Advances in Immunotherapy Sanjiv Agarwala, MD, FASCO View PDF Melanoma: Novel Advances in Immunotherapy Sanjiv Agarwala, MD, FASCO View Video Immunotherapy Session Sanjiv Agarwala, MD; Pedro Barata, MD; Ahmed Zakari, MD; Pedro G. Solivan, MD View Video Promising Immunotherapy for Melanoma Sanjiv S. Agarwala, MD View PDF Immunotherapy & Targeted Therapy in Melanoma Sanjiv S. Agarwala, MD View PDF Immunotherapy and Targeted Therapy in Melanoma Sanjiv S. Agarwala, MD View PDF Immunotherapy & Targeted Therapy in Melanoma Sanjiv S. Agarwala, MD View Video Promising Immunotherapy for Melanoma Sanjiv S. Agarwala, MD View Video Targeted Therapies in Cancer: Is Targeting the Same Mutation Relevant Across Histology and Tumor Type? Shivaani Kummar (OHSU) View PDF Progress in CAR-T Cell Therapies Stephen Forman, MD View Video Progress in CAR-T Cell Therapies Stephen J. Forman, MD View PDF Role of Interleukins in TIME to Improve Immunotherapy Efficacy Suresh Ramalingam, MD View PDF Role of Interleukins in TIME to Improve Immunotherapy Efficacy Suresh Ramalingam, MD View Video Upfront Treatment for Common Ovarian Cancer (High Grade Serous) Versus Rare Histologies-- Focus on PARPi and Other Targeted Therapies Tara Castellano, MD View PDF Upfront Treatment for Common Ovarian Cancer (High Grade Serous) Versus Rare Histologies-- Focus on PARPi and Other Targeted Therapies Tara Castellano, MD View Video Immunotherapy Updates in Melanoma Thach-Giao Truong, MD View PDF Immunotherapy in Gynecologic Malignancies Thomas Herzog, MD View PDF Immunotherapy in Gynecologic Malignancies Thomas Herzog, MD View Video Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies Thomas Herzog, MD View PDF Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies Thomas Herzog, MD View Video What Comes After Immunotherapy Failure in Terms of More Immunomodulation (Anti-Angiogenic Agents, IL-15, OX-40 and Others)? Ticiana Leal, MD View PDF What Comes After Immunotherapy Failure in Terms of More Immunomodulation (Anti-Angiogenic Agents, IL-15, OX-40 and Others)? Ticiana Leal, MD View Video Outside the box applications of Cryoablation Afshin Gangi, MD View PDF Navigation systems becoming mainstream Afshin Gangi, MD View PDF
